MetLife, Inc. vs Bank of America Corporation — Stock Comparison
Q·Score Breakdown
6.1
Hold
Overall
7.6
Buy
Quality
Health
Growth
Valuation
Sentiment
MET
67% of 18 covering analysts rate it Buy or Strong Buy.
⚠ negative free cash flow.
BAC
Earnings growing 23% year-over-year on 12% revenue growth.
Analyst Consensus
BUY
Target $89.06 (+10.9%)
16 analysts
BUY
Target $62.93 (+17.9%)
23 analysts
Fundamentals
MET
BAC
17.0×
Trailing P/E
13.3×
7.3×
Forward P/E
10.6×
4.4%
Profit Margin
29.0%
23.4%
Gross Margin
0.0%
12.0%
ROE
10.6%
27.6%
Revenue Growth
11.8%
-34.2%
Earnings Growth
23.3%
0.73
Beta
1.24
—
Price / Book
—
$52.4B
Market Cap
$380.6B
$67 – $84
52-Week Range
$40 – $58
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.